Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-06-07
1997-06-03
Datlow, Philip I.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514252, 540575, 544364, 544365, A61K 31435, A61K 3155, C07D40112, C07D41314
Patent
active
056355033
ABSTRACT:
A series of non-peptidergic antagonists of NPY have been synthesized and are comprised of piperazine and homopiperazine derivatives of 4-phenyl-1,4-dihydropyridines of Formula (I). ##STR1## As antagonists of NPY-induced feeding behavior, these compounds are expected to act as effective anorexiant agents in promoting weight loss and treating eating disorders.
REFERENCES:
patent: 4755512 (1988-07-01), Poindexter et al.
patent: 4829076 (1989-05-01), Szilagyi et al.
patent: 4868181 (1989-09-01), Johnson et al.
patent: 5166147 (1992-11-01), Earl
patent: 5166148 (1992-11-01), Aldrich et al.
Aritomi et al, Chem. Pharm. Bull., 28 (11), 3163-71 (1980).
Bruce Marc
Johnson Graham
Kozlowski Michael
LeBoulluec Karen
Monkovic Ivo
Bristol--Myers Squibb Company
Datlow Philip I.
Ryan Richard P.
LandOfFree
Dihydropyridine npy antagonists: piperazine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dihydropyridine npy antagonists: piperazine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dihydropyridine npy antagonists: piperazine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-391844